You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKinsey
Johnson and Johnson
Baxter
Dow

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 6,581,775

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,581,775
Title: Method of external genital cleansing and prophylactic kit
Abstract:A method of external genital cleansing and prophylactic kit are disclosed. The kit includes wipes having topical microbicides, personal lubricants, sterile water or sterile water-based solutions disposed on or impregnated therein. The wipes are packaged in conjunction with a condom and when used in accordance with the teaching of this invention work to inhibit transmission of STDs particularly including HIV. Wipes provided in the kit may be used to cleanse the external portions of the genitals before application of the provided condom. After removal of the condom, one or more wipes are to be used to cleanse the external portions of the genitals.
Inventor(s): Hagopian; Garo (Montebello, CA)
Assignee:
Application Number:09/927,944
Patent Claims:see list of patent claims

Details for Patent 6,581,775

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
McKesson
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.